These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6121902)

  • 1. Monohydroxymetabolites of phencyclidine (PCP): activities and urinary excretion by rat, dog and mouse.
    Cone EJ; Vaupel DB; Yousefnejad D
    J Pharm Pharmacol; 1982 Mar; 34(3):197-9. PubMed ID: 6121902
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic polymorphism of cytochrome P-450-dependent phencyclidine hydroxylation in mice. Comparison of phencyclidine hydroxylation in humans.
    Holsztynska EJ; Weber WW; Domino EF
    Drug Metab Dispos; 1991; 19(1):48-53. PubMed ID: 1673421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxy metabolites of phencyclidine. Identification and quantitation of two novel metabolites.
    Gole DJ; Pirat JL; Kamenka JM; Domino EF
    Drug Metab Dispos; 1988; 16(3):386-91. PubMed ID: 2900729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some factors affecting phencyclidine biotransformation by human liver and placenta.
    Pohorecki R; Rayburn W; Coon WW; Domino EF
    Drug Metab Dispos; 1989; 17(3):271-4. PubMed ID: 2568907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel phencyclidine metabolites formed in vitro by rabbit microsomal metabolism.
    Herber R; Perrin R; Ziegler JM; Villoutreix J; Minn A; Siest G
    Xenobiotica; 1991 Nov; 21(11):1493-9. PubMed ID: 1763523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of phencyclidine, its metabolites, and derivatives by gas chromatography with nitrogen-phosphorus detection: application for in vivo and in vitro biotransformation studies.
    Holsztynska EJ; Domino EF
    J Anal Toxicol; 1986; 10(3):107-15. PubMed ID: 3724069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-dependent differences in the pharmacological actions and pharmacokinetics of phencyclidine in rats.
    Nabeshima T; Yamaguchi K; Yamada K; Hiramatsu M; Kuwabara Y; Furukawa H; Kameyama T
    Eur J Pharmacol; 1984 Jan; 97(3-4):217-27. PubMed ID: 6538506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotransformation of phencyclidine.
    Holsztynska EJ; Domino EF
    Drug Metab Rev; 1985-1986; 16(3):285-320. PubMed ID: 3914938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolites of phencyclidine.
    Wong LK; Biemann K
    Clin Toxicol; 1976; 9(4):583-91. PubMed ID: 975754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha carbon oxidation of some phencyclidine analogues by rat tissue and its pharmacological implications.
    Stefek M; Ransom RW; DiStefano EW; Cho AK
    Xenobiotica; 1990 Jun; 20(6):591-600. PubMed ID: 2171233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gas-liquid chromatography assay for phencyclidine and its metabolites.
    Kammerer RC; Di Stefano E; Schmitz D
    J Anal Toxicol; 1980; 4(6):293-8. PubMed ID: 7206659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chronic nicotine pre-treatment on phencyclidine (PCP) disposition in the rat.
    Vadlamani NL; Pontani RB; Misra AL
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):4-12. PubMed ID: 6651404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
    Kamenka JM; Chiche B; Goudal R; Geneste P; Vignon J; Vincent JP; Lazdunski M
    J Med Chem; 1982 Apr; 25(4):431-5. PubMed ID: 6279847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".
    A Michely JA; Manier SK; Caspar AT; Brandt SD; Wallach J; Maurer HH
    Curr Neuropharmacol; 2017; 15(5):692-712. PubMed ID: 27758707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the amino acid metabolite of phencyclidine by selected ion monitoring.
    Syracuse CD; Kuhnert BR; Golden NL; Bagby BS
    Biomed Environ Mass Spectrom; 1986 Mar; 13(3):113-5. PubMed ID: 2938650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dispositional kinetics of phencyclidine and its N-ethylamine analogue in rats.
    Chakrabarti S; Law FC
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):383-8. PubMed ID: 6673975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of phencyclidine (PCP) in urine and blood using gas chromatography-mass spectrometry (GC-MS).
    Ferguson AM; Garg U
    Methods Mol Biol; 2010; 603():461-7. PubMed ID: 20077098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of reactive metabolites to the in vivo hepatic clearance of phencyclidine (PCP).
    Zorbas MA; Owens SM
    NIDA Res Monogr; 1990; 105():429-30. PubMed ID: 1876062
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization and autoradiographic visualization of (+)-[3H]SKF10,047 binding in rat and mouse brain: further evidence for phencyclidine/"sigma opiate" receptor commonality.
    Sircar R; Nichtenhauser R; Ieni JR; Zukin SR
    J Pharmacol Exp Ther; 1986 May; 237(2):681-8. PubMed ID: 3009795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophilic affinity ligands for the phencyclidine (PCP) receptor.
    Lessor RA; Mattson MV; Rice KC; Jacobson AE
    NIDA Res Monogr; 1986; 67():138-44. PubMed ID: 3018571
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.